TMPRSS5 and cardioembolic stroke: Taken together, TMPRSS5 represents a potentially promising therapeutic target for atrial fibrillation and cardioembolic stroke, and further research is warranted to decipher the mechanism through which it protects against cardiovascular and neurological diseases.